Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.315,97
-0,49%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sonus Pharmaceuticals (MM) (SNUS) Sonus Pharmaceuticals (MM) (SNUS) Notizie

SNUS

Sonus (SNUS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNUS
DataOraFonteTitoloSimboloCompagnia
21/08/200815:42PR Newswire (US)Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading onNASDAQ:SNUS
07/08/200822:41Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:SNUSSonus Pharmaceuticals (MM)
05/08/200823:02Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:SNUSSonus Pharmaceuticals (MM)
21/07/200812:01Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
17/07/200821:10PR Newswire (US)Sonus Pharmaceuticals Receives Favorable NASDAQ DecisionNASDAQ:SNUSSonus Pharmaceuticals (MM)
03/07/200822:21Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
30/05/200817:37Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
30/05/200812:30Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
28/05/200813:35PR Newswire (US)Sonus Pharmaceuticals and OncoGenex Technologies to MergeNASDAQ:SNUSSonus Pharmaceuticals (MM)
29/04/200822:36Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Amended Annual Report (10-K/A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
20/03/200822:57Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNUSSonus Pharmaceuticals (MM)
14/03/200822:02Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:SNUSSonus Pharmaceuticals (MM)
13/02/200815:43Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Statement of Ownership (SC 13G)NASDAQ:SNUSSonus Pharmaceuticals (MM)
24/09/200719:41Edgar (US Regulatory)Sonus Pharmaceuticals Inc (Other) (8-K)NASDAQ:SNUSSonus Pharmaceuticals (MM)
03/08/200717:00Business WireSonus Pharmaceuticals Highlights Corporate Progress and Reports Second Quarter Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
19/07/200723:30Business WireSonus Pharmaceuticals to Release Second Quarter Financial Results and Hold Quarterly Conference Call on August 3NASDAQ:SNUSSonus Pharmaceuticals (MM)
13/06/200714:30Business WireSonus Pharmaceuticals Awarded Patent for TOCOSOL(R) Camptothecin, the Company's Second Oncology Product CandidateNASDAQ:SNUSSonus Pharmaceuticals (MM)
04/06/200722:30Business WireSonus Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:SNUSSonus Pharmaceuticals (MM)
09/05/200722:15Business WireSonus Pharmaceuticals Highlights Progress and Reports First Quarter Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
08/05/200701:39Business WireSonus Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare ConferenceNASDAQ:SNUSSonus Pharmaceuticals (MM)
04/05/200701:04Business WireSonus Pharmaceuticals to Release First Quarter Financial Results and Hold Conference Call on May 9NASDAQ:SNUSSonus Pharmaceuticals (MM)
19/03/200723:39Business WireSonus Pharmaceuticals to Present at WBBA Invest Northwest(TM)NASDAQ:SNUSSonus Pharmaceuticals (MM)
14/03/200721:15Business WireSonus Pharmaceuticals Reviews Key Achievements in 2006 and Reports Fourth Quarter and Full Year Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
08/03/200700:20Business WireSonus Pharmaceuticals to Release Fourth Quarter and Full Year 2006 Financial Results and Hold Year-end Conference Call on MarchNASDAQ:SNUSSonus Pharmaceuticals (MM)
07/12/200623:30Business WireSonus Pharmaceuticals to Participate in RBC Capital Markets Healthcare Conference, December 13NASDAQ:SNUSSonus Pharmaceuticals (MM)
21/11/200623:30Business WireSonus Pharmaceuticals to Present at Lazard Capital Markets Third Annual Life Sciences Conference, November 29NASDAQ:SNUSSonus Pharmaceuticals (MM)
16/11/200614:30Business WireSonus Pharmaceuticals Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel in MetastaticNASDAQ:SNUSSonus Pharmaceuticals (MM)
08/11/200622:07Business WireSonus Pharmaceuticals Updates Corporate Progress and Reports Third Quarter Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
31/10/200622:30Business WireSonus Pharmaceuticals to Release Third Quarter Financial Results and Hold Quarterly Conference Call November 8NASDAQ:SNUSSonus Pharmaceuticals (MM)
28/09/200614:30Business WireSonus Pharmaceuticals Initiates Phase 1 Clinical Trial for Company's Second Anti-cancer Drug, TOCOSOL(R) CamptothecinNASDAQ:SNUSSonus Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNUS

La tua Cronologia

BIT
UC8FQB
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network